Sanofi Joins The Ranks of $35/vial Insulin, Adds New Unbranded Insulin to Product Lineup
Yesterday, Sanofi U.S. made an announcement: Effective on July 1, 2022, the company will lower out-of-pocket cost of insulin for uninsured patients and expand access in underserved communities (in reality, the lower prices are available to anyone including those who have insurance deductibles to satisfy). The press release can be viewed athttps://www.news.sanofi.us/2022-06-29-Sanofi-to-lower-out-of-pocket-cost-of-insulin-for-uninsured-patients-and-expand-access-in-underserved-communities.Sanofi has been a laggard relative to its rivals Lilly and Novo Nordisk. For example, in 2019, both Lilly and Novo Nordisk each announced...
Source: Scott's Web Log - July 1, 2022 Category: Endocrinology Tags: Sanofi Aventis Sanofi-Aventis 2022 drug prices Euro API insulin insulin prices Source Type: blogs
Getting Sick and Going Broke – CVS, Credit Cards, and Crippling Medical Debt
BY MIKE MAGEE
The Medical-Industrial Complex is swarming with grifters. This is to be expected when you build a purposefully complex system designed to advance profitability for small and large players alike. The $4T operation payrolling 1 in 5 American workers is, in large part, a hidden economy, one built by professional tricksters, designed by Fortune 100 firms with mountains of lobbyists, but reinforced as well by friendly doctors and hospitals engaged in petty and small scale swindling who justify their predatory actions as entrepreneurial, innovative, and purposeful means of necessary financial survival.
Wh...
Source: The Health Care Blog - June 27, 2022 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: Health Policy CVS Medical Industrial Complex PBMs Source Type: blogs
Health Tech Start-up Spry Secures New Investment to Further Strengthen Its Omnichannel Patient Management Platform for Physical Therapists
The round was led by Eight Roads Ventures with participation from F-Prime Capital and Together Fund.
Funds will be used to accelerate the company’s mission to build the future of practice management for physical rehabilitation
Spry, an end-to-end patient and practice management SaaS platform for physical therapists, today announced that it has successfully completed a new round of funding to accelerate its mission to build the future of practice management for physical rehabilitation. With this new round, the company has raised over US $10 million to date. The round was led by Eight Roads Ventures, ...
Source: EMR and HIPAA - June 24, 2022 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Brijraj Bhuptani Carl Byers Dr. Prem Pavoor EHR Funding Eight Roads Ventures F-Prime Capital Health IT Funding Health IT Fundings Health IT Investment Manav Garg Physical Therapy Practice Managemen Source Type: blogs
Larry Ellison ’ s Vision of a National EHR Database as Part of Cerner Acquisition
A couple weeks ago, Oracle’s acquisition of Cerner closed and Oracle held an event to announce the vision for the The Future of Healthcare. Much has been written about Larry Ellison’s vision of what he called a “National EHR Database.” I wanted to give it a few weeks to sit before I commented, but it’s certainly worthy of comment.
First, it’s worth noting that Larry Ellison’s main job as CEO of Oracle is to set the vision for the company and that includes setting the vision for what he wants Oracle to accomplish with the acquisition of Cerner. CEOs visions at large corporatio...
Source: EMR and HIPAA - June 23, 2022 Category: Information Technology Authors: John Lynn Tags: C-Suite Leadership EMR-EHR Health IT Company Healthcare IT Hospital - Health System Interoperability Cerner EHR Sharing Epic Healthcare Privacy Larry Ellison Life Sciences National EHR Database Oracle Pharma Public Health Source Type: blogs
OTC Birth Control Pills –Just What The Doctor Ordered
Jeffrey A. SingerLast week, at its annual meeting, the American Medical Associationvoted to join the American College of Obstetrics and Gynecology and the American Academy of Family Physicians in calling on the Food and Drug Administration to make birth control pills available over the counter. As I have writtenhere, ACOG and AAFP have been calling for making hormonal contraception available over the counter for decades. While late to the game, the AMA ’s endorsement of OTC birth control is a welcome development.Two drug companies,HRA Pharma andCadence Health have been workingsince 2016 to develop new birth control pi...
Source: Cato-at-liberty - June 21, 2022 Category: American Health Authors: Jeffrey A. Singer Source Type: blogs
The New Buzz: These Are The Top Examples Of Digital Therapeutics
Digital Therapeutics or DTx in short is one of the latest buzzwords in the digital health ecosystem. Unlike others (NFT, Metaverse just to name a few) however, we see DTx as a meaningful trend that has the capacity to bring short-term, substantial improvements in personalised healthcare.
What is Digital Therapeutics?
The definition by the Digital Therapeutics Alliance, the main professional hub is:
“Digital therapeutics (DTx) deliver evidence-based therapeutic interventions that are driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease. They are used inde...
Source: The Medical Futurist - June 21, 2022 Category: Information Technology Authors: Andrea Koncz Tags: TMF Digital Health Research Future of Medicine Health Sensors & Trackers Telemedicine & Smartphones software chronic pain apps cancer care mental health DTx digital therapeutics eczema Atopic dermatitis sleep disorders Source Type: blogs
How the Civica Insulin Announcement Could Be Disruptive to the PBM Kickback Scheme
Yours truly has written an article. I have given some more serious thought to theCivica insulin announcement made on March 3, 2022 (my article has a link to the original press release) and I think it could be very disruptive to what I have dubbed the " PBM Kickback Scheme " . You can read my assessment below, or athttps://www.slideshare.net/ScottStrumello/civica-insulin-assessment.Ironically, this month ' sNew England Journal of Medicine also has a very interesting (and similar) analysis of the exact same topic (the Civica insulin announcement) in its " Perspective " section in an article entitled " A Radical Treatment for...
Source: Scott's Web Log - June 10, 2022 Category: Endocrinology Tags: 2022 Biocon Biosimilar biosimilars Civica Civica Rx CivicaRx insulin Semglee Viatris Source Type: blogs
Why Is Nutrigenomics The Biggest Flop In Digital Health?
If somebody had told me five years ago that I’d sooner review an A.I. guided portable ultrasound device than a nutrigenomics test, I would have laughed so hard. Yet, here we are, this ultrasound test is almost a year old now, and where is a nutrigenomics test I could finally lay my hands on? Not even close.
This is THE digital health technology I have been waiting for the longest and still had no chance to try. At the moment I can’t name a single service, a single direct-to-consumer (DTC) solution focusing on this area while being available and being backed by scientific evidence.
Why is that? I can name fo...
Source: The Medical Futurist - June 7, 2022 Category: Information Technology Authors: Andrea Koncz Tags: TMF Lifestyle medicine Biotechnology Future of Food Genomics Personalized Medicine nutrigenomics nutritients how to eat dna food test dna diet Source Type: blogs
Fight Aging! Newsletter, May 30th 2022
In conclusion, fisetin supplementation may be a novel strategy to target excess cellular senescence and thereby reduce mitochondrial ROS to improve NO-mediated endothelial function with aging.
Exercise Upregulates BDNF Expression to Promote Dopamine Release and Brain Function
https://www.fightaging.org/archives/2022/05/exercise-upregulates-bdnf-expression-to-promote-dopamine-release-and-brain-function/
Researchers have in the past shown that exercise results in greater amounts of BDNF, which in turn promotes neurogenesis. Here, this line of research is extended to show that exercise results in an increa...
Source: Fight Aging! - May 29, 2022 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
The Mental Health ‘Formulary of the Future’? Otsuka’s Work in DTx, Psychedelics, & More
By JESSICA DaMASSA, WTF HEALTH
Otsuka Pharmaceuticals is expanding its mental health formulary – looking beyond traditional medications to psychedelics, and to the “intersection of technology and psychiatry” with digital therapeutics currently in clinical trials for Major Depressive Disorder. Kabir Nath, Senior Managing Director of Otsuka’s Global Pharmaceutical Business, lets us in on the thinking behind these bold moves, why the pharma co is even innovating to expand the spectrum of treatments available for mental illness in the first place, and how soon these new therapies will reach patients.
“Follow t...
Source: The Health Care Blog - May 27, 2022 Category: Consumer Health News Authors: Christina Liu Tags: Health Tech Health Technology Jessica DaMassa WTF Health dtx Kabir Nath Mental Health Otsuka Pharmaceuticals psychedelics Source Type: blogs
A Discussion of Progress Towards Reprogramming Therapies with a Turn.bio Co-Founder
The Lifespan.io team here talks with one of the co-founders of Turn.bio, one of the first biotech ventures focused on partial reprogramming as a basis for rejuvenation therapies. Their initial technology involves the delivery of lipid nanoparticles that encapsulate mRNA for temporary expression of the Yamanaka factors. Full reprogramming dedifferentiates and rejuvenates cells, turning somatic cells into induced pluripotent stem cells with youthful epigenetic patterns. Epigenetic rejuvenation is desirable, but producing pluripotent cells in the body is not. Partial reprogramming attempts to apply reprogramming factors for l...
Source: Fight Aging! - May 27, 2022 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
The Sovereignty Network will help patients make money out of your health data
By HAMISH MACDONALD
Being a patient has always meant being at the bottom of a trickle-down pyramid in healthcare. Late to get information, our test results, our data, and as for earning the money that our healthcare data is worth – that is something the healthcare industry does without our permission or dues. We are left right out of that.
But what if we made clinical data tools available on your device, so that you could build the most valuable set of healthcare data that exists about you anywhere? What if you owned that particular data set as your personal asset? Well, we think that researchers are going to...
Source: The Health Care Blog - May 16, 2022 Category: Consumer Health News Authors: matthew holt Tags: Data Health Tech Hamish MacDonald Health Data Privacy The Sovereignty Network Source Type: blogs
Digital & Tech Are Changing Pfizer: Pharma Co ’s Chief Digital & Technology Officer Takes Us Inside
By JESSICA DaMASSA, WTF HEALTH
What does digital transformation look like at a global healthcare giant like Pfizer? Lidia Fonseca, Pfizer’s Chief Digital & Technology Officer, shares her strategy for building the life sciences company’s digital data and technology solutions, including her thinking about digital therapeutics, digital diagnostics, and digital biomarkers. As Lidia puts it, this is not about trying to simply implement a “digital strategy,” but is, instead, about building a “business strategy for digital world.”
There’s probably no better story that illustrates how that “business strat...
Source: The Health Care Blog - May 11, 2022 Category: Consumer Health News Authors: Christina Liu Tags: Health Tech Health Technology Jessica DaMassa WTF Health digital health Lidia Fonseca Pfizer Source Type: blogs
A path toward clinical trial diversity
Minority and marginalized communities have historically been underrepresented in local and federal governments and in dozens of private sectors globally. Pharma is no different; there exists a steep chasm that drugmakers have yet to bridge concerning research and trials. The longer this gulf exists, the harder it becomes to address – the feelings of mistrust,Read more …A path toward clinical trial diversity originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - May 8, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/liz-beatty" rel="tag" data-wpel-link="internal" > Liz Beatty < /a > < /span > Tags: Conditions Medications Source Type: blogs
